scholarly journals Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study

2019 ◽  
Vol 25 (6) ◽  
Author(s):  
Laura K. Ferris ◽  
Darrell S Rigel ◽  
Daniel M Siegel ◽  
Maral K Skelsey ◽  
Gary L. Peck ◽  
...  
2020 ◽  
Vol 19 (3) ◽  
pp. 257-262
Author(s):  
Brook Brouha ◽  
Laura Ferris ◽  
Maral Skelsey ◽  
Gary Peck ◽  
Ronald Moy ◽  
...  

2018 ◽  
Vol 2 ◽  
pp. S69
Author(s):  
Laura Ferris ◽  
Burkhard Jansen ◽  
Zuxu Yao ◽  
Jim Rock ◽  
Maral Skelsey ◽  
...  

Abstract not available. Disclosures: Study sponsored by Dermtech. Copyright 2018 SKIN


2020 ◽  
Vol 83 (6) ◽  
pp. AB147
Author(s):  
Brook Brouha ◽  
Laura K. Ferris ◽  
Maral K. Skelsey ◽  
Gary Peck ◽  
Zuxu Yao ◽  
...  

2021 ◽  
Vol 42 (2) ◽  
Author(s):  
Jimmy Oi Santoso ◽  
Nurnajmia Curie Proklamartina ◽  
Roy Christian

NSTEACS is subset of ACS that may present with a wide degree of stenosis from normal vessels to severe obstruction. Identification of which population of NSTEACS that has normal vessels has attracted a great attention. Several trials on non-invasive imaging such as coronary CT have been largely investigated. Current available trials have showed that coronary CT is accurately identify significant stenosis in patients with NSTEACS thus can be used to rule out the disease and reduce the need and duration of unneeded antithrombotic. However, several limitations of the studies has to be taken into account when translating into clinical practice. Nevertheless, current evidence are showing promising results on the role of coronary CT in management of NSTEACS.


2003 ◽  
Vol 2 (1) ◽  
pp. 131
Author(s):  
A ZAPHIRIOU ◽  
S ROBB ◽  
G MENDEZ ◽  
T MURRAYTHOMAS ◽  
S HARDMAN ◽  
...  

GYNECOLOGY ◽  
2020 ◽  
Vol 21 (6) ◽  
pp. 36-40
Author(s):  
Anna G. Burduli ◽  
Natalia A. Kitsilovskaya ◽  
Yuliya V. Sukhova ◽  
Irina A. Vedikhina ◽  
Tatiana Y. Ivanets ◽  
...  

The review presents data on metabolites in the follicular fluid (FF) from the perspective of reproductive medicine and their use in order to predict outcomes of assisted reproductive technology (ART) programs. It considers various components of this biological medium (hormones, lipids, melatonin, etc.) with an assessment of their predictive value in prognosis of the effectiveness of in vitro fertilization (IVF) programs. The data on experimental directions in this field and the prospects for their use in clinical practice are presented. The article emphasizes that the growing clinical need and the unsolved problem of increasing the effectiveness of ART programs determine the need for further studies of the FF composition. Materials and methods. The review includes data related to this topic from foreign and Russian articles found in PubMed which were published in recent years. Results. Given the established fact of a direct effect of FF composition on growth and maturation of oocytes, and further, on the fertilization process, various FF metabolites are actively investigated as non-invasive markers of quality of oocytes/embryos. The article provides data on the experimental directions in this field and the prospects for their use in clinical practice. However, clinical studies of a relation between various FF metabolites levels and outcomes of IVF programs are contradictory. Conclusion. Owing large economic cost for treatment of infertility with IVF, there is need for expansion and intensification of studies to identify and use reliable predictors in prognosis of ART programs outcomes.


Sign in / Sign up

Export Citation Format

Share Document